Preprint · OA via OpenAlex

Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases

Antonio Cuadrado, Ana I. Rojo, Geoffrey Wells, John D. Hayes, Sharon P. Cousin, William L. Rumsey, Otis C. Attucks, Stephen Franklin, Anna–Liisa Levonen, Thomas W. Kensler, Albena T. Dinkova‐Kostova

Nature Reviews Drug Discovery · 2019 · ▲ 1,415 citations

Loss of proteostasis

＋ Sign in to save

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: OpenAlex
DOI: 10.1038/s41573-018-0008-x
Canonical: link ↗
Fetched: 2026-07-26 MST

Cite this

APA

Cuadrado, A., Rojo, A.I., Wells, G., Hayes, J.D., Cousin, S.P., Rumsey, W.L., Attucks, O.C., Franklin, S., Levonen, A., Kensler, T.W., & Dinkova‐Kostova, A.T. (2019). Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. <em>Nature Reviews Drug Discovery</em>. https://doi.org/10.1038/s41573-018-0008-x

Vancouver

Cuadrado A, Rojo AI, Wells G, Hayes JD, Cousin SP, Rumsey WL, et al. Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nature Reviews Drug Discovery. 2019. doi:10.1038/s41573-018-0008-x.

BibTeX

@unpublished{antonio2019Therap, title = {Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases}, author = {Antonio Cuadrado and Ana I. Rojo and Geoffrey Wells and John D. Hayes and Sharon P. Cousin and William L. Rumsey and Otis C. Attucks and Stephen Franklin and Anna–Liisa Levonen and Thomas W. Kensler and Albena T. Dinkova‐Kostova}, journal = {Nature Reviews Drug Discovery}, year = {2019}, doi = {10.1038/s41573-018-0008-x}, }